Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07021014 · ClinicalTrials.gov registry record · NA
NightWare and Cardiovascular Health in Women With PTSD
A NA study, sponsored by University of Colorado, Denver.
- Not yet
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT07021014 is a NA study that has not yet begun recruiting, run by University of Colorado, Denver. The registered enrollment target is 36 participants.
The verdict
NCT07021014, a NA study, has not yet begun recruiting, sponsored by University of Colorado, Denver.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether NightWare therapeutic intervention improves biomarkers of vascular and renal function in premenopausal women with PTSD-related nightmares, and examine whether these improvements restore them to levels observed in age-matched women without PTSD.
Interventions
- DEVICE NightWare
- DEVICE Sham NightWare
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2025-07 |
| Est. Completion | 2028-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07021014
The ClinicalTrials.gov registry entry for NCT07021014 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which NightWare is the first listed.
NCT07021014 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07021014 about?
NCT07021014 is a clinical study titled "NightWare and Cardiovascular Health in Women With PTSD". The purpose of this study is to determine whether NightWare therapeutic intervention improves biomarkers of vascular and renal function in premenopausal women with PTSD-related nightmares, and examine whether these improvements restore them to levels observed in age-matched women without PTSD.
What is the current status of trial NCT07021014?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2025-07. Estimated completion is 2028-07.
What interventions are being tested in trial NCT07021014?
The interventions under investigation include: NightWare (DEVICE), Sham NightWare (DEVICE).
Who is sponsoring clinical trial NCT07021014?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.